Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Join SI Premium – FREE
Krystal Biotech, Inc. (NASDAQ: KRYS) reported Q4 EPS of ($1.25), $0.01 better than the analyst estimate of ($1.26).
For earnings history and earnings-related data on Krystal Biotech, Inc. (KRYS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Kroger meets earnings expectations, revenue tops estimates
- JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
